• What is TMS Therapy^®?
  • About NeuroStar TMS^®
  • NeuroStar TMS Therapy^® — Unique Mechanism of Action
  • TMS Therapy^® – A Key Role in the Treatment of Depression
• NeuroStar^® Clinical Research
  • NeuroStar TMS Therapy^® — Proven Efficacy
  • NeuroStar^® Safety
  • Scientific Publications and Presentations
• NeuroStar TMS Therapy^® System
  • NeuroStar^® System Components
  • The SenStar^® Advantage
  • TMS TrakStar™ Practice Data Management Software
  • Setting Up a NeuroStar^® Practice
  • Physician Experiences with NeuroStar^®
• NeuroStar^® Service & Support
  • NeuroStar^® University Clinical Training
  • Patient Education
  • Practice Support
  • Reimbursement Support
  • Public Relations & Local Outreach
  • StarGuard™ Field Service Solutions
  • NeuroStar^® Providers
• Reimbursement Support
  • Coding and Billing for NeuroStar TMS Therapy^®
  • NeuroStar Reimbursement Support
  • Reimbursement Support Materials
  • Coverage and Medical Policies
• NeuroStar^® Resources
  • Recent Press Coverage
  • Recent Press Releases
  • Events & Exhibits
  • Medical Education Events
  • Press Contact
• Contact Us
  • Healthcare Professional Contact Information

What is TMS Therapy^®?

Transcranial Magnetic Stimulation

Transcranial magnetic stimulation (TMS) therapy is based on knowledge of physical principles dating back nearly 175 years. In 1831, Michael Faraday discovered that a magnetic field could induce an electrical current in a conductor. That discovery has been applied to create a powerful and focused magnetic treatment coil that can be used to stimulate the brain.

Since the 1980s, TMS has been used to study the nerve fibers that carry information about movements from the brain to the spinal cord and onto the muscles. In the late 1990’s physicians began to explore the therapeutic potential of transcranial magnetic stimulation for the treatment of a variety of diseases, with depression being the most thoroughly studied to date. Since then, numerous trials have been conducted to investigate the safety and efficacy of TMS therapy as a treatment for depression, with the two largest randomized trials being conducted with the NeuroStar TMS Therapy^® System.^1,2

NeuroStar^® TMS (Transcranial Magnetic Stimulation) for the Treatment of Depression

NeuroStar TMS (transcranial magnetic stimulation) Therapy for the treatment of depression is a non-invasive, outpatient procedure that uses a pulsed magnetic field, similar in type and strength to those produced by a magnetic resonance imaging (MRI) machine, to stimulate function in brain regions known to affect mood. These regions include the left prefrontal cortex which is directly stimulated by TMS Therapy and deeper regions such as the cingulate cortex which is indirectly activated by TMS.

The NeuroStar TMS Therapy System is the first TMS therapy device cleared by the U.S. Food and Drug Administration (FDA) to treat patients with Major Depressive Disorder (MDD) who have not benefited from initial antidepressant treatment.* The NeuroStar System is the only TMS therapy device that has been studied in large, randomized, controlled clinical trials including over 500 patients. Growing post-market experience with NeuroStar TMS Therapy has shown it to be a safe and effective depression treatment which is used by hundreds of private practice psychiatrists and dozens of psychiatric medical institutions across the United States. Click here to learn more about NeuroStar efficacy data.